Background {#Sec1}
==========

Perforation in the gastrointestinal tract results in complicated intra-abdominal infection (cIAI) that may present either as localized peritonitis with or without abscess formation or as diffuse peritonitis \[[@CR1]\]. The intra-abdominal view (IAV) in cIAI is traditionally classified into generalized or local and clear, purulent, or fecal according to the appearance of the exudate in the abdomen \[[@CR2]\]. Other classifications separate community- or hospital-acquired cIAIs and postoperative or non-postoperative IAIs \[[@CR3]\].

In a cIAI, various other findings are often seen in the abdomen, for example, bowel dilatation, bile as exudate, various degrees of fibrin coverage, and redness in the parietal and/or visceral peritoneum.

Even though all surgeons know that a large variety in the IAV exists in patients with cIAI, IAV has not received much attention in previous literature or clinical work. As an example, a patient with acute perforated diverticulitis and a small amount of pus in the pelvis and among small bowel loops, in an otherwise perfectly normally looking abdomen, would be classified as Hinchey III \[[@CR4]\]. The same grade of classification would be used in an abdomen full of pus, with dilated bowel, extensive fibrin coverage, and substantially red peritoneal surfaces all over the abdomen. It seems intuitive that recovery paths of these patients would be different and, therefore, all Hinchey III patients cannot be considered equal only based on the existence of purulent peritonitis \[[@CR5], [@CR6]\].

There is a wide range of disease severity in patients with cIAI. A term severe complicated intra-abdominal sepsis (SCIAS) to describe sepsis-related organ dysfunctions combined with cIAI specifically due to a disruption in the gastrointestinal tract was introduced in an article by Kirkpatrick et al. \[[@CR7]\]. A variety of risk factors for SCIAS or mortality have been identified, preoperative sepsis with associated organ dysfunctions and septic shock being the most important ones \[[@CR3], [@CR8]--[@CR10]\]. Other crucial factors include the physiological reserve of the patient, comorbidities, immunosuppressive medications, and the anatomical derangement caused by the acute disease. There are multiple scoring systems, general and cIAI-specific combining these factors to predict severe outcomes but no one system works satisfyingly \[[@CR11]\]. These systems include limited data of the IAV.

The aim of this prospective study was to systematically analyze components of IAV and their association to SCIAS or 30-day mortality.

Methods {#Sec2}
=======

Patients and setting {#Sec3}
--------------------

This study was conducted as a prospective cohort study in a single academic center that serves both as a secondary and a tertiary referral center. Institutional ethics committee and review board approved the study design. A written informed consent was obtained from all the patients included in the study. The study period was 2 years, starting on 31 March 2016 and ending on 31 March 2018.

Eligible patients were adult (over 18 years old) patients undergoing surgical intervention because of a cIAI. Patients with pancreatitis, acute mesenteric ischemia, or trauma were excluded. During the study period, electronic operating room logs were manually browsed for all abdominal emergency operations to verify that all patients with a cIAI were identified.

Intra-abdominal view {#Sec4}
--------------------

Data regarding intra-abdominal findings was collected on a paper sheet form filled by the operating surgeon after the operation (Additional file [1](#MOESM1){ref-type="media"}). In the form, the abdomen was divided into six areas: right and left upper supramesocolic area, right and left lower and paracolic area, mid-abdomen small bowel area, and pelvic area (below the promontorium). Small and/or large bowel dilatation was recorded as well as the type of exudate (clear, purulent, fecal, bile) by area. If any area contained fecal or bile exudate, the peritonitis was classified as fecal or bile peritonitis, respectively. If both were present, the peritonitis was classified according to the predominant exudate. In addition, the amount of fibrin by area (none, mild, or substantial) and redness of the peritoneum by area (none, mild, or substantial) were recorded. Further, the localization of infection in the peritoneum by area (parietal and/or visceral, excluding the pelvic area) was recorded. The difference between mild and substantial finding was a subjective estimation based on clinical judgment and experience.

Definitions {#Sec5}
-----------

Comorbidities were classified according to the Charlson Comorbidity Index \[[@CR12]\]. The classification of sepsis was recorded as in the Sepsis-III guidelines, i.e., sepsis is an acute change of total Sequential Organ Failure Assessment (SOFA) score two or more and septic shock is sepsis with persisting hypotension requiring vasopressors to maintain mean arterial pressure ≥ 65 mmHg and a persistent serum lactate level \> 2 mmol/l despite adequate volume resuscitation \[[@CR10]\]. Other reported scores were the Mannheim Peritonitis Index, World Society of Emergency Surgery (WSES) Sepsis Severity Score for patients with cIAIs, Acute Physiology And Chronic Health Evaluation II (APACHE-II), Clavien-Dindo complication classification, and the SOFA scores in patients admitted to the ICU \[[@CR2], [@CR13]--[@CR16]\]. For the Clavien-Dindo classification, the most serious in-hospital complication was used. Preoperative organ dysfunctions (grade IV) or antibiotic treatment for cIAI were not documented as complications. Only new onset organ dysfunctions or complications that significantly contributed to the worsening of preoperative organ dysfunctions were classified as grade IV \[[@CR17]\]. Immunosuppression was defined according to the WSES Sepsis Severity Score, i.e., chronic use of glucocorticoids, immunosuppressive medication, chemotherapy within 30 days, or lymphatic disease. The primary outcome was a composite outcome of SCIAS or 30-day mortality. SCIAS translated to ICU admission due to organ dysfunctions. Similar definition has also been used in a recent study \[[@CR11]\].

Statistical analyses {#Sec6}
--------------------

Descriptive statistics are demonstrated in number, percentage, mean, median, and interquartile range (IQR), where appropriate. Univariate analyses were made using binary logistic regression for categorical variables, Mantel-Haenszel linear-by-linear association chi-squared test for ordinal variables, and Mann-Whitney *U* test or Kruskal-Wallis test for continuous variables without normal distribution, where appropriate. Nonparametric correlations between continuous variables were tested with Spearman's rho test. Multivariate analysis was conducted using binary logistic regression. Multivariate goodness-of-fit was tested using Hosmer-Lemeshow test, and model performance was tested using Nagelkerke *R*^2^. Variables for multivariate analysis were chosen from the results of the univariate analysis. After logical reclassification in some variables, the most significant variable from each IAV component (perforated organ, extent of peritonitis, bowel dilatation, type of exudate, fibrin coverage, and redness in peritoneum) was chosen. Different logistic regression models were tested with different combinations of variables, and the model with the highest Nagelkerke *R*^2^ value was chosen. The scoring system was built according to the regression coefficients in the logistic regression equation. A receiver operating characteristic (ROC) curve was plotted, and area under ROC curve (AUROC) calculated. Two-tailed *P* value below 0.05 was considered significant, and odds ratio (OR) values are presented with 95% confidence intervals (CI). Analyses mentioned above were performed using a SPSS© Statistics version 22 for Mac (IBM©, Armonk, NY, USA). Internal validation on logistic model was done with bootstrapping and by calculating optimism-adjusted AUC \[[@CR18]\]. This analysis was done using R (R Foundation for Statistical Computing, Vienna, Austria. URL [https://www.R-project.org/](https://www.r-project.org/).) with pROC package \[[@CR19]\] and R function for optimism-adjusted AUC \[[@CR20]\].

Power calculation {#Sec7}
-----------------

Power calculations for this study were based on the primary outcome measure, i.e., SCIAS or 30-day mortality. In order to perform a statistically appropriate multivariate analysis with seven variables, we calculated the need for a minimum of 49 patients with the primary outcome event. Based on previous reports, 10--25% of patients with cIAI will meet the primary outcome \[[@CR8], [@CR13]\]. For power calculation purposes, we estimated that 17% of cIAI patients would meet the primary outcome event resulting in a need to recruit at least 288 patients.

Results {#Sec8}
=======

During the 2-year study period, there were 657 operated patients with cIAIs filling the inclusion; please see the modified flow diagram (Fig. [1](#Fig1){ref-type="fig"}). The most common reasons for not recruiting patients were failure to attempt recruiting and not suspecting cIAI preoperatively.Fig. 1Patient flow chart

A total of 283 patients with properly filled IAV form were included and analyzed. Patient characteristics, together with the intra- and postoperative data, are presented in Table [1](#Tab1){ref-type="table"}, describing the study cohort. Briefly, 132 (47%) were male with a median age of 64 years. Sepsis was present in 60 (21%) and septic shock in 19 (7%) patients preoperatively. The most common sources of cIAI were the appendix (*n* = 109, 39%) and colorectal (*n* = 101, 36%). The median length of hospital stay was 6 days, and 57 (20%) patients were admitted to the ICU with a median peak SOFA score of 8. All patients admitted to the ICU had a SOFA score of at least 1. Twenty-nine (10%) patients died within 30 days, and SCIAS or mortality was encountered in 71 (25%) patients.Table 1Patient characteristicsPreoperative*n* (%) (total *n* = 283) Sex, male132 (47) Age, years64 (49--74)^a^ BMI21 (19--24)^a^ Charlson Comorbidity Index1 (0--5)^a^ Immunosuppression54 (19) Malignant diseases  Local solid malignant tumor35 (12)  Solid metastatic tumor or lymphoma45 (16) Sepsis classification  No sepsis204 (72)  Sepsis60 (21)  Septic shock19 (7) Hospital-acquired cIAI62 (22)Intraoperative*n* (%) Delay from symptoms to operation \< 24 h79 (28) Perforated organ  Gastroduodenal32 (11)  Small bowel30 (11)  Colorectal101 (36)  Appendix109 (39)  Gallbladder11 (4) Operation  Laparotomy152 (54)  Laparoscopy110 (39)  Converted from laparoscopy to laparotomy21 (7) Open abdomen5 (2) Postoperative peritonitis38 (13) Mannheim Peritonitis Index26 (22--32)^a^ WSES Sepsis Severity Score6 (3--9)^a^ APACHE-II9 (6--15)^a^Postoperative*n* (%) CRP, highest value, mg/l304 (244--364)^a^ Reoperations36 (13) Postoperative abscess28 (10) Clavien-Dindo classification, in-hospital  0111 (39)  147 (17)  238 (13)  3a28 (10)  3b25 (9)  4a7 (2)  4b3 (1)  524 (8) Length of hospital stay, days6 (3--11)^a^ ICU admission57 (20)  Renal replacement therapy2 (1)  Peak SOFA score at ICU8 (6--10)^a^ Prolonged (\> 12 h) recovery room stay25 (9) Mortality, 30 days29 (10) SCIAS or 30-day mortality71 (25) Mortality, 90 days37 (13)*Abbreviations*: *BMI* body mass index, *cIAI* complicated intra-abdominal infection, *WSES* World Society of Emergency Surgery, *APACHE* Acute Physiology and Chronic Health Evaluation, *CRP* C-reactive protein, *ICU* intensive care unit, *SCIAS* severe complicated intra-abdominal sepsis^a^Continuous variables are presented as median (interquartile range)

Several different components of the IAV were associated with the primary outcome (Table [2](#Tab2){ref-type="table"}). Some components of the IAV were reclassified according to the results to build the multivariate analysis (marked with "\*" in Table [2](#Tab2){ref-type="table"}). Non-appendiceal source of cIAI, diffuse peritonitis (four or more out of six areas), dilatation of the colon only, fecal or bile as exudate, substantial fibrin deposits found in five or more areas, and substantial redness found in four or more areas were chosen for the multivariate analysis. Correlations between continuous variables were tested, and all results were significant (*P* \< 0.001). Correlation coefficients for the amount of substantial redness by area were 0.433 for the amount of substantial fibrin by area and 0.385 for the extent of peritonitis by area. For the amount of substantial fibrin by area and extent of peritonitis by area, the correlation coefficient was 0.293.Table 2Univariate binary logistic regression of components of the intra-abdominal view for severe complicated intra-abdominal sepsis (SCIAS) or 30-day mortalityRisk factor*n* (%)SCIAS or 30-day mortality, *n* (%)OR (95% CI)*P* value*B*Perforated organ Appendix109 (39)5 (5)Reference*\< 0.001* Gallbladder11 (4)4 (36)11.89 (2.60--54.42)*0.001*2.475 Colorectal101 (36)37 (37)12.03 (4.49--32.18)*\< 0.001*2.487 Gastroduodenal32 (11)12 (38)12.48 (3.96--39.33)*\< 0.001*2.524 Small bowel30 (11)13 (43)15.91 (5.03--50.33)*\< 0.001*2.767 Non-appendiceal source\*174 (62)66 (38)12.71 (4.93--32.81)*\< 0.001*2.542Extent of peritonitis by number of affected areas 130 (11)4 (13)Reference*0.001* 247 (17)7 (15)1.14 (0.30--4.28)0.8490.129 329 (10)1 (3)0.23 (0.02--2.21)0.204− 1.460 432 (11)8 (25)2.17 (.58--8.13)0.2520.773 532 (11)7 (22)1.82 (0.47--6.99)0.3830.599 6113 (40)44 (39)4.15 (1.35--12.69)*0.013*1.422 Diffuse peritonitis (≥ 4 areas)\*177 (63)59 (33)3.92 (1.99--7.71)*\< 0.001*1.365Bowel dilatation No bowel dilatation164 (58)35 (21)Reference0.097 Small bowel only77 (27)19 (25)1.21 (0.64--2.29)0.5630.188 Colon only\*19 (7)8 (42)2.68 (1.00--7.17)*0.050*0.986 Small bowel and colon23 (8)9 (39)2.37 (0.95--5.93)0.0650.863Type of exudate Clear16 (6)3 (19)Reference*0.001* Purulent160 (57)27 (17)0.88 (0.24--3.30)0.849− 0.128 Fecal85 (30)30 (35)2.36 (0.62--8.95)0.2060.860 Bile22 (8)11 (52)4.33 (0.96--19.58)0.0571.466 Fecal or bile\*107 (38)41 (38)3.02 (1.74--5.26)*\< 0.001*1.106Extent of fibrin by number of affected areas 037 (13)15 (41)Reference*\< 0.001* 177 (27)12 (16)0.27 (0.11--0.67)*0.004*− 1.306 246 (16)7 (15)0.26 (0.09--0.74)0.120− 1.335 328 (10)3 (11)0.18 (0.05--0.69)0.130− 1.737 431 (11)6 (19)0.35 (0.12--1.06)0.640− 1.044 524 (9)10 (42)1.05 (0.37--2.98)0.9300.047 639 (14)18 (46)1.26 (0.51--3.12)0.6220.229Amount of substantial fibrin by number of affected areas 0140 (49)33 (24)Reference*0.016* 172 (25)12 (17)0.65 (0.31--1.35)0.246− 0.433 225 (9)6 (24)1.02 (0.38--2.78)0.9630.024 319 (7)7 (37)1.89 (0.69--5.20)0.2160.637 410 (4)2 (20)0.81 (0.16--4.01)0.797− 0.210 56 (2)4 (67)6.49 (1.14--37.01)*0.035*1.869 611 (4)7 (64)5.67 (1.56--20.59)*0.008*1.736 Substantial fibrin ≥ 5 or more areas\*17 (6)11 (65)6.29 (2.2--17.73)*\< 0.001*1.840Extent of redness by number of affected areas 017 (6)8 (47)Reference*\< 0.001* 141 (14)6 (15)0.19 (0.05--0.70)*0.012*− 1.646 255 (19)7 (13)0.16 (0.05--0.57)*0.004*− 1.808 332 (11)3 (9)0.12 (0.03--0.53)*0.006*− 2.151 432 (11)7 (22)0.32 (0.09--1.12)0.074− 1.155 527 (10)7 (26)0.39 (0.11--1.42)0.155− 0.932 678 (28)33 (42)0.83 (0.29--2.37)0.720− 1.192Amount of substantial redness by number of affected areas 0125 (44)26 (21)Reference*\< 0.001* 173 (26)10 (14)0.60 (0.27--1.34)0.214− 0.504 234 (12)10 (29)1.59 (0.68--3.73)0.2900.462 321 (7)5 (24)1.19 (0.40--3.55)0.7550.174 49 (3)5 (56)4.76 (1.19--18.99)*0.027*1.560 53 (1)2 (67)7.62 (0.66--87.29)0.1032.030 618 (6)13 (72)9.90 (3.24--30.29)*\< 0.001*2.293 Substantial redness ≥ 4 or more areas\*30 (11)20 (67)7.92 (3.49--17.97)*\< 0.001*2.070Localization of cIAI non-parietal (only visceral)49 (17)11 (22)0.84 (0.40--1.75)0.639− 1.094Method: enter, all variables categorical. Italics indicate statistical significance*Abbreviations*: *OR* odds ratio, *B* regression coefficient, *cIAI* complicated intra-abdominal infection\*Included in multivariate analysis

In the multivariate binary logistic regression analysis, four components of the IAV were found independently significantly associated with the primary outcome (Table [3](#Tab3){ref-type="table"}). In an ascending OR order, these factors were fecal or bile as exudate, diffuse peritonitis, substantial redness in four or more areas, and a non-appendiceal source. AUROC for this logistic model was 0.812 (95% CI 0.761--0.865). Internal validity of the logistic model was tested with bootstrapping. Distribution of the AUROC value in the bootstrap sample is shown in Additional file [2](#MOESM2){ref-type="media"}. Optimism-adjusted AUROC for the logistic model was 0.802. Hosmer-Lemeshow goodness-of-fit test significance was 0.36 showing the model had adequate fit. Model performance was tested using Nagelkerke *R*^2^ with a result of 0.36.Table 3Multivariate binary logistic regression of the intra-abdominal view for severe complicated intra-abdominal sepsis (SCIAS) or 30-day mortalityRisk factorSCIAS or 30-day mortality OR (95% CI)*P* value*B*IAV scoreExudate fecal or bile1.98 (1.05--3.73)0.0340.6851Diffuse peritonitis (≥ 4 areas)2.15 (1.02--4.55)0.0450.7671Substantial redness (≥ 4 areas)5.73 (2.12--15.44)0.0011.7452Non-appendiceal source11.20 (4.11--30.54)\< 0.0012.4163Method: forward LR, all variables categorical*Abbreviations*: *OR* odds ratio, *CI* confidence interval, *B* regression coefficient, *IAV* intra-abdominal view (score = 1.3 × *B* to nearest integer)

The IAV score is also presented in Table [3](#Tab3){ref-type="table"}. Regression coefficients were multiplied by 1.3, and the nearest integer was the score for each variable. AUROC for IAV score predicting SCIAS or 30-day mortality was 0.81, and it remained unchanged from the original logistic model. As shown in Fig. [2](#Fig2){ref-type="fig"}, the IAV score performed nearly as good as other scores in predicting SCIAS or mortality. With the help of the ROC curve (Fig. [2](#Fig2){ref-type="fig"}), two cutoff points were chosen to divide patients to low (0--2 points), medium (3--5 points), and high score (6--7 points) groups. These groups were compared for various different outcomes (Table [4](#Tab4){ref-type="table"}).Fig. 2Receiver operating characteristic (ROC) curve for the intra-abdominal view (IAV) score and comparisons to other scores. Abbreviations: WSES World Society of Emergency Surgery, APACHE Acute Physiology And Chronic Health Evaluation, MPI Mannheim Peritonitis index, CI confidence intervalTable 4The intra-abdominal view (IAV) score evaluation; low, middle, and high scores with various outcomesAll patientsLow scoreMedium scoreHigh score*P* value\*IAV score4 (1--4)\*\*0--23--56--7Number of patients, *n* (%)283 (100)102 (36)158 (56)23 (8)Length of stay, days\*\*6 (3--10)3 (2--5)8 (6--13)10 (6--18)\< 0.001Clavien-Dindo ≥ 3, *n* (%)87 (31)14 (14)62 (39)11 (48)\< 0.001ICU admission, *n* (%)57 (20)2 (2)39 (25)16 (70)\< 0.001Mortality, 30 days, *n* (%)29 (10)1 (1)22 (14)6 (26)\< 0.001SCIAS or 30-day mortality, *n* (%)71 (25)3 (3)50 (32)17 (74)\< 0.001*Abbreviation*: *ICU* intensive care unit\**P* values are calculated using linear-by-linear association for dichotomous variables and Kruskal-Wallis test for continuous variable\*\*Continuous variables are presented as median (interquartile range)

Because of the dynamic nature of organ dysfunctions, an additional analysis was made to evaluate whether the IAV score could predict the course of organ dysfunction (Fig. [3](#Fig3){ref-type="fig"}). Patients with preoperative organ dysfunctions had a higher median IAV score (4, IQR 4--5) compared to patients without organ dysfunctions (3, IQR 1--4), *P* \< 0.001. Of the 204 patients without preoperative organ dysfunctions, 13 (6%) were admitted to the ICU or died, and these patients had a significantly higher IAV score (4, IQR 3--5) compared to the patients who recovered without ICU treatment (3, IQR 1--4), *P* = 0.008. On the other hand, patients whose preoperative organ dysfunctions resolved quickly without ICU treatment had a lower IAV score (3, IQR 1--4) compared to the ones who were admitted to the ICU or died (5, IQR 4--6), *P* \< 0.001.Fig. 3The intra-abdominal view (IAV) score correlations with pre- and postoperative organ dysfunctions. Legend: IAV scores are presented as median (interquartile range), \*Mann-Whitney *U* test

Subgroup analysis {#Sec9}
-----------------

Due to the much better prognosis in acute appendicitis as the source of cIAI, we performed a subgroup analysis with a non-appendiceal source of cIAI. There were 174 patients, of which 27 (16%) died within 30 days, 53 (30%) were admitted to the ICU, and 66 (38%) had a SCIAS. A multivariate analysis was performed with the Table [3](#Tab3){ref-type="table"} variables, without source of infection, using the enter method. The results were substantial redness in ≥ 4 areas (OR 5.09, 95% CI 1.71--15.13, *P* 0.003, *B* 1.628), fecal or bile as exudate (OR 2.06, 95% CI 1.06--4.03, *P* 0.034, *B* 0.725), and diffuse peritonitis (OR 2.14, 95% CI 0.97--4.72, *P* 0.059, *B* 0.761). Hosmer-Lemeshow test showed a non-significant value of 0.91 and Nagelkerke *R*^2^ 0.19.

Discussion {#Sec10}
==========

This pioneer prospective study of the IAV in patients with cIAI recognized several independent factors associated with SCIAS or 30-day mortality. Based on these factors, an IAV score was developed and its performance further analyzed.

We chose a composite outcome of either ICU admission due to acute organ dysfunctions (=SCIAS) or 30-day mortality as the primary outcome. All patients admitted to the ICU had acute organ dysfunctions. With this outcome, all patients with a severe outcome were recognized, since some patients may die without being admitted to the ICU. This may be due to ICU admission refusals, or a more surprising death without diagnosed previous organ dysfunctions.

The results from the multivariate analysis are somewhat expected. A completely new finding was that having substantial redness in four or more out of six areas in the abdomen was independently associated with the primary outcome. Intuitively, it seems logical. The inflammatory response of the peritoneum is characterized by enhanced vascular perfusion, accumulation of macrophages with subsequent attraction of more immune cells, and release of pro- and anti-inflammatory mediators \[[@CR21]--[@CR23]\]. The stronger the inflammation process, the more visible the redness of the peritoneum. Patients with appendicitis have substantially better prognosis compared to other cIAIs \[[@CR3], [@CR13]\]. Even when adjusting for other IAV factors, patients having other sources than appendicitis was the risk factor with the highest OR. In future cIAI studies, it should be considered if appendicitis should be studied as a separate entirety with different outcome measures due to a much less severe course of the disease. Having a diffuse, rather than localized cIAI, the risk for SCIAS or 30-day mortality increased threefold. This risk seems obvious and has also been identified by the previously existing scoring systems \[[@CR2], [@CR13]\]. When the type of exudate was fecal or bile, compared to clear or purulent, there was a more than twofold increase for the primary outcome. This factor is taken into account in the Mannheim Peritonitis Index \[[@CR2]\] but not in other cIAI-specific or sepsis scoring systems \[[@CR11], [@CR13]\].

Fibrin coverage was not independently associated with the primary outcome. Fibrin correlated with redness but the redness was more significant in multivariate analysis and therefore fibrin did not stand out as an independent risk factor. Venous blood flow from the visceral peritoneum goes first through the portal vein into the liver, whereas parietal venous flow goes directly to systemic circulation. Also, the visceral and parietal peritoneum have distinct innervations and the surface area of the visceral peritoneum is much larger than that of the parietal peritoneum \[[@CR24]\]. However, localization of the cIAI only in the visceral peritoneum did not correlate with outcome.

The values of Nagelkerke *R*^2^ 0.36 and AUROC 0.81 for the IAV score clearly show that IAV only accounts for a limited, although substantial, part of prognostic factors for SCIAS or 30-day mortality. However, it is quite surprising that the AUROC for the IAV score is of the same magnitude as in the more comprehensive scoring systems, since organ dysfunctions and comorbidities are not included in the model \[[@CR11]\]. These results emphasize the role of the surgeons' perception of cIAI disease severity when looking into the abdomen while operating. A subgroup analysis of patients with a non-appendiceal source of cIAI showed very similar results and was not considered to provide any additional value.

The IAV score was tested by dividing patients into three score groups (Table [4](#Tab4){ref-type="table"}), and it was found to correlate significantly with a variety of different outcomes. In Fig. [3](#Fig3){ref-type="fig"}, it is shown that patients who improve quickly, without ICU treatment, from preoperative organ dysfunctions have a lower IAV score. In addition, patients without preoperative organ dysfunctions who eventually develop SCIAS or die have a higher score than patients who recover without organ dysfunctions. It is not surprising that the worse the macroscopic view of the peritonitis is, the worse the outcome. Nevertheless, this is the first study that shows and quantifies it.

Interestingly, in the univariate analyses, when the extent of fibrin and the redness by area was zero, the risk for the primary outcome was high, resulting in a U-shaped curve within the variable. The reason for this finding can only be speculated and it warrants further research, but the phenomenon might be associated with an impaired immune response to cIAI.

It is well known that organ dysfunctions are the most important risk factors for poor outcome \[[@CR8], [@CR11], [@CR13]\]. Another major factor not included in this study's model is the comorbidities. These factors were not included in this study since the focus of this study was an in-depth analysis of the IAV. In future studies, including components of the IAV to a more comprehensive scoring system could provide a better scoring system than the current ones.

This study has some limitations. This was a prospective single-center study with a limited number of patients. Less than half of the recruitable patients during the study period were included in the study. The evaluation of the amount of fibrin deposits as well as redness of the peritoneum was based on subjective evaluation leading most likely into some interobserver variability. Also, the IAV score has not been externally validated.

Conclusions {#Sec11}
===========

Classification of peritonitis should not be based only on the type of the exudate or presence of diffuse peritonitis. An IAV score, which includes fecal or bile as exudate, diffuse peritonitis, substantial redness in four or more of the six areas of the abdomen, and non-appendiceal source of cIAI, may provide a simple method to classify patients with cIAI. The IAV score predicts various outcomes well and correlates with preoperative organ dysfunctions and the development of postoperative organ dysfunctions. The concept of including more variables of the IAV to cIAI scoring systems might provide additional value in assessing individual patient disease severity and outcome. However, the IAV score needs external validation before further implementations.
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